Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 5, Number 3—June 1999

Synopsis

Adhesins as Targets for Vaccine Development

Theresa M. Wizemann, John E. Adamou, and Solomon LangermannComments to Author 
Author affiliations: MedImmune, Inc., Gaithersburg, Maryland, USA

Main Article

Table 1

Adhesins of gram-negative bacteria

Adhesin Strain Ligand Reference
Pili familya Hultgren (33)
PapG Escherichia coli Gala(1-4)Gal in globoseries of glycolipids
SfaS E. coli a-sialyl-2 3-b-galactose
FimH E. coli Mannose-oligosaccharides
HifE Haemophilus influenzae Sialylyganglioside-GM1
PrsG E. coli Gala(1-4)Gal in globoseries of glycolipids
MrkD Klebsiella pneumoniae Type V collagen
FHA Bordetella pertussis Sulfated sugars on cell-surface glycoconjugates Brennan (34)
Pertactin B. pertussis Integrins Brennan (34)
HMW1/HMW2 H. influenzae Human epithelial cells St. Geme (35)
Hia H. influenzae Human conjunctival cells Barenkamp (36)
Leb-binding adhesin Helicobacter pylori Fucosylated Leb histo-blood group antigens Ilver (37)

aRepresentative examples from the large family of pilus-associated adhesins. FHA, filamentous hemagglutinin; HMW, high molecular weight; Hia, H. influenzae adhesin

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO